Improving Clinical Development in EBP Settings

​How model based drug development leads to smarter, more predictable trials

White Paper

Improving Clinical Development in EBP Settings

This insight brief explores the benefits of Model-based Drug Development (MBDD) for emerging biopharma companies. MBDD is the process of leveraging modeling and simulation throughout the project life cycle to predict trial results and inform planning and design decisions. MBDD is a proven and often effective method for reducing the costly delays and changes that plague typical development efforts by enabling project teams to select the right dose, estimate patient recruitment, and optimize protocol, study and program design.

Future Clinical Development Insights